腹腔镜剜除术与胰腺切除术治疗小胰腺神经内分泌肿瘤的长期功能与肿瘤学结局比较
该回顾性队列研究纳入2001年至2021年间在东北大学医院接受腹腔镜手术的67例小(<2 cm)高分化胰腺神经内分泌肿瘤患者,比较腹腔镜剜除术(LE)与腹腔镜规则胰腺切除术(LRP)的预后。结果显示两组5年无复发生存率无显著差异(LE 100% vs. LRP 96.0%,P=0.313),但LE组术后新发糖尿病(NODM)的5年累积发生率显著低于LRP组(9.1% vs. 43.2%,P=0.0181)。多因素分析确定LRP、年龄>60岁和非功能性肿瘤是NODM的独立预测因素。
要点
- 对于小的高分化胰腺神经内分泌肿瘤,腹腔镜剜除术的肿瘤学结局与规则胰腺切除术相当。
- 腹腔镜剜除术可显著降低术后新发糖尿病的长期风险。
- 患者选择需满足肿瘤<2 cm且距主胰管>3 mm。
核心结论
- 在适当选择患者的前提下,小的高分化胰腺神经内分泌肿瘤行腹腔镜剜除术,其肿瘤学结局和围手术期安全性与腹腔镜规则胰腺切除术相当,且长期内分泌功能保护更优。
研究设计与样本
- 回顾性队列研究,纳入2001年1月至2021年12月在东北大学医院接受腹腔镜手术的67例小(<2 cm)高分化胰腺神经内分泌肿瘤患者。
主要发现
- 中位随访时间:LRP组78.1个月,LE组135.4个月。
- 两组手术时间、出血量和术后并发症无显著差异。
- 5年无复发生存率:LE组100%,LRP组96.0%(P=0.313)。
- 5年新发糖尿病累积发生率:LE组9.1%,LRP组43.2%(P=0.0181)。
- 多因素分析显示LRP(HR=7.71,95%CI 1.03-57.8;P=0.0469)、年龄>60岁(HR=4.49,95%CI 1.62-12.4;P=0.0039)和非功能性肿瘤(HR=2.78,95%CI 1.08-7.19;P=0.0342)是NODM的独立预测因素。
临床怎么用
- 对于小(<2 cm)且高分化、非侵袭性、距主胰管>3 mm的胰腺神经内分泌肿瘤,可考虑腹腔镜剜除术以保留胰腺内分泌功能。
局限性
- 回顾性研究设计,样本量较小(67例),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic surgery is being increasingly used for pancreatic neuroendocrine neoplasms (PanNENs). Although laparoscopic regular pancreatectomy (LRP) is frequently performed, laparoscopic enucleation (LE), a parenchyma-sparing technique, may be better in preserving pancreatic endocrine function. However, limited evidence is available regarding the long-term oncological and endocrine outcomes of these two laparoscopic methods. This study aimed to compare the surgical and prognostic outcomes and endocrine function preservation in patients undergoing LE and LRP for well-differentiated, non-invasive PanNEN. METHODS: This retrospective cohort study included 67 consecutive patients who underwent laparoscopic surgery for small (< 2 cm) well-differentiated PanNEN at Tohoku University Hospital between January 2001 and December 2021. LE was performed for small tumors (< 2 cm) located away (> 3 mm) from the main pancreatic duct. Clinical characteristics, surgical details, tumor characteristics, postoperative complications, recurrence-free survival (RFS), overall survival (OS), and long-term endocrine function were retrospectively analyzed. Kaplan-Meier analysis, Cox regression, and the Mann-Whitney U test were used for statistical comparisons. RESULTS: The median follow-up was 78.1 months for LRP and 135.4 months for LE. No significant differences were observed between the two groups in terms of the operative time, blood loss, or postoperative complications. Five-year RFS was excellent and comparable in both groups (LE, 100%, LRP 96.0%; P = 0.313). Notably, LE was associated with a significantly reduced incidence of postoperative new-onset diabetes mellitus (NODM) compared to LRP (5-year cumulative incidence: 9.1% vs. 43.2%; P = 0.0181). Multivariate analysis identified LRP (hazard ratio [HR] = 7.71, 95% confidence interval [CI]:1.03-57.8; P = 0.0469), older age (> 60 years) (HR = 4.49, 95% CI 1.62-12.4; P = 0.0039), and non-functional tumor (HR = 2.78, 95% CI 1.08-7.19; P = 0.0342) as independent predictors of NODM. CONCLUSION: Given appropriate patient selection, LE of small well-differentiated PanNENs provides comparable oncological outcomes, perioperative safety, and superior long-term endocrine function preservation compared to LRP.
引用
- Miura T, Aoki S, Maeda S, et al. Laparoscopic enucleation vs. pancreatectomy for small pancreatic neuroendocrine neoplasms: long-term functional and oncological outcomes. Surg Endosc. 2025. PMID: 40879775. doi:10.1007/s00464-025-11935-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。